An interventional study of Intervention and Control in Knee Osteoarthritis, sponsored by University of Delaware. Completed at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2025-01-01.
Sponsored by University of Delaware · Not applicable, Interventional, and Treatment
The objective of this project is to examine the efficacy of an innovative Telehealth Physical Therapy (PT) program for adults with knee osteoarthritis (OA) to increase physical activity over 12 weeks in adults with knee OA compared to a control group receiving web-based resources about knee OA. One hundred individuals with knee osteoarthritis (OA), who are over the age of 45, and are also looking to move more, will be randomized into a brief or expanded intervention group. The control includes an online, guided video orientation from a physical therapist to web resources for strengthening exercises, physical activity, and pain management strategies for knee OA. The intervention includes up to 5 online consultations with a physical therapist over a 12-week period who will prescribe strengthening exercises, physical activity goals, and pain management strategies for knee OA.
Delaware PEAK (Physical therapy Exercise and Activity for Knee osteoarthritis) is a delivered remotely by a physical therapist over 5 one-on-one video conference (Zoom Platform) consultations lasting 45 to 60 minutes each over 12 weeks. Each consultation focuses on strengthening exercises, physical activity goals, and education to debunk common OA-related myths and misconceptions. Delaware PEAK utilizes a well-established behavioral counseling method, Motivational Interviewing, to increase self-efficacy (confidence) related to exercise, while delivering all aspects of the intervention.
The objective of this project is to examine the efficacy of Delaware PEAK to increase physical activity in adults with knee OA compared to a control group receiving web-based resources about knee OA and exercise. The rationale for our study is that there is a need to examine whether PEAK can directly target the mismatch between OA recommendations and practice patterns. Our central hypothesis is that Delaware PEAK will increase physical activity and will increase the belief that exercise is helpful and not harmful, compared with a control group receiving web-based OA treatment resources. Successful completion of this proposal will provide the evidence necessary to scale up this low-cost intervention, with the goal of increasing the number of adults who use exercise to manage their knee OA and thus reducing the burden of disease.
The primary endpoint of our study is to examine the efficacy of a physical therapist-delivered exercise intervention (Delaware PEAK) to increase MVPA over 12 weeks compared to a control group receiving web-based resources about knee OA and exercise.
The secondary analyses endpoint of our study is to examine the efficacy of a physical therapist-delivered exercise intervention (Delaware PEAK) to increase health beliefs in Physical Exercise and Physical Therapy, light physical activity (LPA), and steps per day, over 24 weeks compared to a control group receiving web-based resources about knee OA and exercise. We also will assess change in MVPA over 24 weeks.
Our exploratory endpoints include change in pain, symptoms, function in activities of daily living, function in sport and recreation, and quality of life over 12 weeks and 24 weeks. We will also examine change in treatment expectations before and after randomization. Lastly, we will examine change in treatment adherence from 12 to 24 weeks among those in the expanded intervention group.
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's enrollment of 103 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →University of Delaware is the lead sponsor of 125 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
meet the National Institute for Health and Care Excellence Osteoarthritis (NICE) clinical criteria:
Exclusion Criteria:
Virtual consultation sessions with a physical therapist, focusing on lower extremity strengthening exercises, physical activity (i.e., walking), and education about knee osteoarthritis.
Behavioral: Intervention
Web-based resources on knee osteoarthritis, including an overview of knee osteoarthritis, brief anatomy of the knee and how that is related to pain, different types of arthritis pain and how to manage it, and how to be active with arthritis.
Behavioral: Control
Participants in the Intervention arm will receive five virtual consultation sessions, delivered by a physical therapist over 12 weeks (at Weeks 1, 2, 4, 7, and 10) and lasting approximately 45-60 minutes each. Each session will focus on lower extremity strengthening exercises, physical activity (i.e., walking), and education about knee osteoarthritis. Participants will be provided with an exercise manual, tracking log, educational manual, and a step counter. Participants will be prescribed up to 6 exercises (quadriceps, hip abductor/gluteal, hamstrings/gluteal, calf, balance) and daily walking step goals. Progression will be a joint decision by the participant and physical therapist. Education will include information on knee osteoarthritis, managing pain, being active, weight loss, dealing with setbacks, and progressing activity. The physical therapist will also discuss barriers and facilitators to meeting and progressing goals as appropriate.
Participants in the Control arm will receive access to a study-specific website that navigates them to a variety of web-based resources on knee osteoarthritis. Topics for the various resources include an overview of knee osteoarthritis, brief anatomy of the knee and how that is related to pain, different types of arthritis pain and how to manage it, and how to be active with arthritis. Sessions range from 20 - 70+ minutes.
Change in Moderate-to-vigorous Intensity Physical Activity
Actigraph GT3X monitor to be worn over the right hip during waking hours. Participants will be instructed to wear the monitor for 7 consecutive days, and then return the monitor via mail in a pre-addressed, pre-stamped envelope that is provided. Units are in minutes/day of Moderate to vigorous intensity physical activity (MVPA), min 0, max 1440, with higher scores representing more time in MVPA
Time frame: Baseline to 12 weeks as primary outcome Baseline to 24 weeks as secondary outcome
Change in Treatment Beliefs of Physical Therapy: Positive
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Therapy measure, which is a 9-item questionnaire that assesses health beliefs (positive and negative) related to physical therapy. Scores of the TOA PT Positive are on a scale of 7 to 28 with higher scores mean better outcome, i.e., more positive treatment beliefs
Time frame: Baseline, 12 weeks, and 24 weeks
Change in Treatment Beliefs of Physical Exercise: Positive
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Exercise measure, which is a 13-item questionnaire that assesses health beliefs (positive and negative) related to physical activity. Scores of the TOA PE Positive are on a scale of 7 to 28 with higher scores mean better outcome, i.e., more positive treatment beliefs
Time frame: Baseline, 12 weeks, and 24 weeks
Change in Light Intensity Physical Activity (LPA)
Data collected using the ActiGraph GT3x activity monitor will also be used to assess change in minutes/week of LPA between baseline and both follow-up timepoints. Minutes/day of LPA can range from 0 minutes/day to 1,440 minutes/day (24 hours x 60 minutes).
Time frame: Baseline, 12 weeks, and 24 weeks
Change in Steps/Day
Data collected using the ActiGraph GT3x activity monitor will also be used to assess change in average steps/day between baseline and both follow-up timepoints. Steps/day can be any value greater than or equal to 0. Valid data includes those who wore the ActiGraph for \> 4 days.
Time frame: Baseline, 12 weeks, and 24 weeks
Change in Treatment Beliefs of Physical Therapy: Negative
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Therapy measure, which is a 9-item questionnaire that assesses health beliefs (positive and negative) related to physical therapy. Scores of the TOA PT Negative are on a scale of 4 to 16 with higher scores mean worse outcome, i.e., more negative treatment beliefs
Time frame: Baseline, 12 weeks, and 24 weeks
Change in Treatment Beliefs of Physical Exercise: Negative
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Exercise measure, which is a 13-item questionnaire that assesses health beliefs (positive and negative) related to physical activity. Scores of the TOA PE Negative are on a scale of 4 to 16 with higher scores mean worse outcome, i.e., more negative treatment beliefs
Time frame: Baseline, 12 weeks, and 24 weeks
Exploratory Outcome: Change in Knee Pain (Visual Analogue Scale)
Change in knee pain will be measured using a single-item Visual Analog Scale (VAS) question in which the participant will indicate their pain in each knee. Scores range from 0-100 where 0 is no pain and 100 is the worst pain imaginable. An index knee to be used for analysis is defined as the knee with worse pain at baseline. Scores of the Knee pain Visual Analogue Scale are on a scale of 0 to 100 with higher scores mean worse outcome, i.e., more pain
Time frame: Baseline, 12 weeks, and 24 weeks
Exploratory Outcome: Change in Knee Injury and OA Outcome Score (KOOS) Pain Subscale
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Pain, min 0, max 100, with higher scores representing a better outcome
Time frame: Baseline, 12 weeks, and 24 weeks
Exploratory Outcome: Change in Treatment Expectations
The participant will complete a Treatment Expectations Question, which asks the participant how effective they expect the intervention to be for their knee. This question will be collected at the baseline timepoint: right before and right after randomization. Answers will be expressed as frequencies and percentages for each of the following categories: No effect at all, Minimal improvement, Moderate improvement, Large improvement, and Complete recovery, as well as reported as an increase, decrease, or no change in treatment expectations. Score ranges from 1 to 5 with higher scores representing higher expectations of improvement following treatment.
Time frame: Baseline and after randomization
Exploratory Outcome: Change in Exercise Adherence Rating Scale (EARS)
For the Expanded Intervention, adherence to strengthening exercises and physical activity will be measured using the Exercise Adherence Rating Scale (EARS). The EARS includes 6 items whose total score ranges from 0 to 24, where a higher score indicates greater adherence.
Time frame: 12 weeks and 24 weeks
Exploratory Outcome: Change in Knee Injury and OA Outcome Score (KOOS) Symptoms Subscale
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Symptoms, min 0, max 100, with higher scores representing a better outcome
Time frame: Baseline, 12 weeks, and 24 weeks
Exploratory Outcome: Change in Knee Injury and OA Outcome Score (KOOS) ADL Subscale
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS ADL, min 0, max 100, with higher scores representing a better outcome
Time frame: Baseline, 12 weeks, and 24 weeks
Exploratory Outcome: Change in Knee Injury and OA Outcome Score (KOOS) Sports and Recreation Subscale
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Sports and Recreation, min 0, max 100, with higher scores representing a better outcome
Time frame: Baseline, 12 weeks, and 24 weeks
Exploratory Outcome: Change in Knee Injury and OA Outcome Score (KOOS) Quality of Life Subscale
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Quality of Life, min 0, max 100, with higher scores representing a better outcome
Time frame: Baseline, 12 weeks, and 24 weeks
| Milestone | Expanded Intervention | Brief Intervention |
|---|---|---|
| Started | 51 | 52 |
| Completed | 45 | 51 |
| Not completed | 6 | 1 |
| Withdrew: Withdrawal by subject | 2 | 1 |
| Withdrew: Lost to follow-up | 4 | 0 |
| Milestone | Expanded Intervention | Brief Intervention |
|---|---|---|
| Started | 45 | 51 |
| Completed | 41 | 46 |
| Not completed | 4 | 5 |
| Withdrew: Withdrawal by subject | 2 | 1 |
| Withdrew: Lost to follow-up | 2 | 4 |
Actigraph GT3X monitor to be worn over the right hip during waking hours. Participants will be instructed to wear the monitor for 7 consecutive days, and then return the monitor via mail in a pre-addressed, pre-stamped envelope that is provided. Units are in minutes/day of Moderate to vigorous intensity physical activity (MVPA), min 0, max 1440, with higher scores representing more time in MVPA
| min/day of MVPA | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 0.7 (-4.8 to 6.2) | 2.6 (-2.6 to 7.7) |
| 24 weeks - Baseline | 2.7 (-2.9 to 8.2) | 1.6 (-3.6 to 6.8) |
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Therapy measure, which is a 9-item questionnaire that assesses health beliefs (positive and negative) related to physical therapy. Scores of the TOA PT Positive are on a scale of 7 to 28 with higher scores mean better outcome, i.e., more positive treatment beliefs
| units on a scale | Intervention | Brief Intervention |
|---|---|---|
| 12 weeks - Baseline | 1.0 (-0.7 to 2.8) | 0.4 (-2.1 to 1.3) |
| 24 weeks - Baseline | 0.4 (-1.4 to 2.2) | -0.6 (-2.2 to 1.1) |
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Exercise measure, which is a 13-item questionnaire that assesses health beliefs (positive and negative) related to physical activity. Scores of the TOA PE Positive are on a scale of 7 to 28 with higher scores mean better outcome, i.e., more positive treatment beliefs
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 1.3 (-0.6 to 3.2) | 0.0 (-1.8 to 1.8) |
| 24 weeks - Baseline | 1.2 (-0.7 to 3.1) | -0.4 (-2.2 to 1.4) |
Data collected using the ActiGraph GT3x activity monitor will also be used to assess change in minutes/week of LPA between baseline and both follow-up timepoints. Minutes/day of LPA can range from 0 minutes/day to 1,440 minutes/day (24 hours x 60 minutes).
| min/day | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 3.8 (-22.6 to 30.2) | 2.6 (-22.0 to 27.3) |
| 24 weeks - Baseline | -3.4 (-30.0 to 23.1) | -13.1 (-38.0 to 11.7) |
Data collected using the ActiGraph GT3x activity monitor will also be used to assess change in average steps/day between baseline and both follow-up timepoints. Steps/day can be any value greater than or equal to 0. Valid data includes those who wore the ActiGraph for \> 4 days.
| Steps/day | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 517.5 (-252.8 to 1287.8) | 259.0 (-462.2 to 980.1) |
| 24 weeks - Baseline | 269.3 (-505.7 to 1044.4) | -206.5 (-933.6 to 520.5) |
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Therapy measure, which is a 9-item questionnaire that assesses health beliefs (positive and negative) related to physical therapy. Scores of the TOA PT Negative are on a scale of 4 to 16 with higher scores mean worse outcome, i.e., more negative treatment beliefs
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | -0.6 (-1.9 to 0.6) | 1.0 (-0.2 to 2.1) |
| 24 weeks - Baseline | -1.0 (-2.2 to 0.3) | 0.5 (-0.6 to 1.7) |
Participants will be asked to complete the treatment Beliefs of OA (TOA) Physical Exercise measure, which is a 13-item questionnaire that assesses health beliefs (positive and negative) related to physical activity. Scores of the TOA PE Negative are on a scale of 4 to 16 with higher scores mean worse outcome, i.e., more negative treatment beliefs
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | -0.6 (-1.9 to 0.6) | 1.0 (-0.2 to 2.1) |
| 24 weeks - Baseline | -1.0 (-2.2 to 0.3) | 0.5 (-0.6 to 1.7) |
Change in knee pain will be measured using a single-item Visual Analog Scale (VAS) question in which the participant will indicate their pain in each knee. Scores range from 0-100 where 0 is no pain and 100 is the worst pain imaginable. An index knee to be used for analysis is defined as the knee with worse pain at baseline. Scores of the Knee pain Visual Analogue Scale are on a scale of 0 to 100 with higher scores mean worse outcome, i.e., more pain
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | -29.7 (-40.5 to -18.9) | -8.8 (-19.1 to 1.6) |
| 24 weeks - Baseline | -25.7 (-36.8 to -14.7) | -14.2 (-24.5 to -3.8) |
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Pain, min 0, max 100, with higher scores representing a better outcome
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 10.6 (5.0 to 16.2) | 3.7 (-1.5 to 8.9) |
| 24 weeks - Baseline | 10.0 (4.3 to 15.6) | 3.8 (-1.5 to 9.0) |
The participant will complete a Treatment Expectations Question, which asks the participant how effective they expect the intervention to be for their knee. This question will be collected at the baseline timepoint: right before and right after randomization. Answers will be expressed as frequencies and percentages for each of the following categories: No effect at all, Minimal improvement, Moderate improvement, Large improvement, and Complete recovery, as well as reported as an increase, decrease, or no change in treatment expectations. Score ranges from 1 to 5 with higher scores representing higher expectations of improvement following treatment.
| units on a scale | Intervention | Control |
|---|---|---|
| Pre-Randomization | 3.1 ± 0.7 | 3.1 ± 0.6 |
| Post-Randomization | 3.0 ± 0.7 | 2.6 ± 0.7 |
For the Expanded Intervention, adherence to strengthening exercises and physical activity will be measured using the Exercise Adherence Rating Scale (EARS). The EARS includes 6 items whose total score ranges from 0 to 24, where a higher score indicates greater adherence.
| units on a scale | Intervention Group |
|---|---|
| 12 weeks | 15.1 ± 6.1 |
| 24 weeks | 11.1 ± 6.6 |
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Symptoms, min 0, max 100, with higher scores representing a better outcome
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 6.0 (1.2 to 10.9) | 2.2 (-2.4 to 6.8) |
| 24 weeks - Baseline | 5.8 (0.9 to 10.7) | 0.6 (-4.0 to 5.1) |
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS ADL, min 0, max 100, with higher scores representing a better outcome
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 12.5 (6.3 to 18.6) | 4.4 (-1.4 to 10.2) |
| 24 weeks - Baseline | 9.5 (3.3 to 15.7) | 4.9 (-0.9 to 10.7) |
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Sports and Recreation, min 0, max 100, with higher scores representing a better outcome
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 15.2 (2.8 to 27.7) | 4.0 (-7.8 to 15.7) |
| 24 weeks - Baseline | 7.0 (-5.6 to 19.6) | 3.7 (-8.0 to 15.5) |
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42-item questionnaire that assesses five domains, including pain, symptoms (other than pain), function in activities of daily living, function in sport and recreation, and quality of life. The KOOS has subscale scores for Pain, Symptoms, ADL Function, Sport \& Recreation Function, and Quality of Life. Scores are transformed to a 0-100 scale with 0 indicating extreme knee problems and 100 indicating no knee problems. KOOS Quality of Life, min 0, max 100, with higher scores representing a better outcome
| units on a scale | Intervention | Control |
|---|---|---|
| 12 weeks - Baseline | 14.4 (7.7 to 21.2) | 5.2 (-1.2 to 11.5) |
| 24 weeks - Baseline | 15.1 (8.3 to 21.9) | 4.5 (-1.9 to 10.8) |
Collected over Adverse events were collected from study enrollment until study completion at the 24 week follow up.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Expanded Intervention | 0/51 (0%) | 0/51 (0%) | 44/51 (86.3%) |
| Brief Intervention | 0/52 (0%) | 3/52 (5.8%) | 10/52 (19.2%) |
| Event | Expanded Intervention | Brief Intervention |
|---|---|---|
| HospitalizationMusculoskeletal and connective tissue disorders | 0/51 | 3/52 |
| Event | Expanded Intervention | Brief Intervention |
|---|---|---|
| OtherMusculoskeletal and connective tissue disorders | 25/51 | 5/52 |
| BackMusculoskeletal and connective tissue disorders | 5/51 | 0/52 |
| KneeMusculoskeletal and connective tissue disorders | 5/51 | 5/52 |
| Ankle/FootMusculoskeletal and connective tissue disorders | 5/51 | 0/52 |
| Hip/ThighMusculoskeletal and connective tissue disorders | 4/51 | 0/52 |
| Age, Continuous(years) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| Mean | 60.7 ± 10.1 | 61.2 ± 8.0 | 60.9 ± 9.1 |
| Sex: Female, Male(Participants) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| Female | 40 | 45 | 85 |
| Male | 11 | 7 | 18 |
| Ethnicity (NIH/OMB)(Participants) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| Hispanic or Latino | 1 | 2 | 3 |
| Not Hispanic or Latino | 50 | 49 | 99 |
| Unknown or Not Reported | 0 | 1 | 1 |
| Race (NIH/OMB)(Participants) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 1 | 2 | 3 |
| Native Hawaiian or Other Pacific Islander | 1 | 0 | 1 |
| Black or African American | 4 | 4 | 8 |
| White | 43 | 44 | 87 |
| More than one race | 1 | 1 | 2 |
| Unknown or Not Reported | 1 | 1 | 2 |
| Weight(kilograms) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| Mean | 96.4 ± 23.1 | 95.9 ± 22.1 | 96.2 ± 22.5 |
| Height(Meters) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| Mean | 1.7 ± 0.1 | 1.6 ± 0.1 | 1.7 ± 0.1 |
| Body Mass Index(Kg/m squared) | Expanded Intervention | Brief Intervention | Total |
|---|---|---|---|
| Mean | 34.4 ± 7.8 | 35.7 ± 8.4 | 35.0 ± 8.1 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Delaware